{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:26Z","timestamp":1790805626202,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40659-015-0051-6","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T12:56:54Z","timestamp":1445950614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Functional disruption of human leukocyte antigen II in human embryonic stem cell"],"prefix":"10.1186","volume":"48","author":[{"given":"Haide","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"issue":"5391","key":"51_CR1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137. doi: 10.1126\/science.282.5391.1145 .","journal-title":"Science"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","volume":"27","author":"JE Smith-Garvin","year":"2009","unstructured":"Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591\u2013619. doi: 10.1146\/annurev.immunol.021908.132706 .","journal-title":"T cell activation. Annu Rev Immunol."},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","volume":"224","author":"BT Fife","year":"2008","unstructured":"Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. 2008;224:166\u201382. doi: 10.1111\/j.1600-065X.2008.00662.x .","journal-title":"Immunol Rev"},{"issue":"1","key":"51_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","volume":"14","author":"ZL Rong","year":"1998","unstructured":"Rong ZL, Wang MY, Hu Z, Stradner M, Zhu SY, Kong HJ, et al. An effective approach to prevent immune rejection of human esc-derived allografts. Cell Stem Cell. 1998;14(1):121\u201330. doi: 10.1016\/J.Stem.2013.11.014 .","journal-title":"Cell Stem Cell"},{"issue":"8","key":"51_CR5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365(8):725\u201333. doi: 10.1056\/NEJMoa1103849 .","journal-title":"N Engl J Med"},{"issue":"10","key":"51_CR6","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1158\/0008-5472.CAN-07-6051","volume":"68","author":"HF Wei","year":"2008","unstructured":"Wei HF, Wang H, Lu B, Li BH, Hou S, Qian WZ, et al. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Cancer Res. 2008;68(10):3854\u201362. doi: 10.1158\/0008-5472.Can-07-6051 .","journal-title":"Cancer Res"},{"issue":"3","key":"51_CR7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12185-010-0520-1","volume":"91","author":"S Senju","year":"2010","unstructured":"Senju S, Hirata S, Motomura Y, Fukuma D, Matsunaga Y, Fukushima S, et al. Pluripotent stem cells as source of dendritic cells for immune therapy. Int J Hematol. 2010;91(3):392\u2013400. doi: 10.1007\/S12185-010-0520-1 .","journal-title":"Int J Hematol"},{"issue":"12","key":"51_CR8","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.4049\/jimmunol.0902493","volume":"183","author":"E Landais","year":"2009","unstructured":"Landais E, Romagnoli PA, Corper AL, Shires J, Altman JD, Wilson IA, et al. New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J Immunol. 2009;183(12):7949\u201357. doi: 10.4049\/jimmunol.0902493 .","journal-title":"J Immunol."},{"issue":"10","key":"51_CR9","first-page":"719","volume":"98","author":"J Zimmer","year":"2005","unstructured":"Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H. Clinical and immunological aspects of HLA class I deficiency. s. 2005;98(10):719\u201327. doi: 10.1093\/Qjmed\/Hci112 .","journal-title":"s"},{"issue":"2","key":"51_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00251-006-0171-9","volume":"59","author":"T Rodriguez","year":"2007","unstructured":"Rodriguez T, Mendez R, Del Campo A, Aptsiauri N, Martin J, Orozco G, et al. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Immunogenetics. 2007;59(2):123\u201333. doi: 10.1007\/s00251-006-0171-9 .","journal-title":"Immunogenetics"},{"issue":"6","key":"51_CR11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s12015-013-9457-0","volume":"9","author":"P Lu","year":"2013","unstructured":"Lu P, Chen J, He L, Ren J, Chen H, Rao L, et al. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin. Stem Cell Rev. 2013;9(6):806\u201313. doi: 10.1007\/s12015-013-9457-0 .","journal-title":"Stem Cell Rev."},{"issue":"6","key":"51_CR12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","volume":"21","author":"L Riolobos","year":"2013","unstructured":"Riolobos L, Hirata RK, Turtle CJ, Wang PR, Gornalusse GG, Zavajlevski M, et al. HLA engineering of human pluripotent stem cells. Mol Ther. 2013;21(6):1232\u201341. doi: 10.1038\/mt.2013.59 .","journal-title":"Mol Ther"},{"issue":"5","key":"51_CR13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/gt.2012.59","volume":"20","author":"M Haruta","year":"2013","unstructured":"Haruta M, Tomita Y, Yuno A, Matsumura K, Ikeda T, Takamatsu K, et al. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells. Gene Ther. 2013;20(5):504\u201313. doi: 10.1038\/Gt.2012.59 .","journal-title":"Gene Ther"},{"key":"51_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-065X.1994.tb00853.x","volume":"138","author":"B Mach","year":"1994","unstructured":"Mach B, Steimle V, Reith W. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol Rev. 1994;138:207\u201321. doi: 10.1111\/j.1600-065X.1994.tb00853.x .","journal-title":"Immunol Rev"},{"issue":"10","key":"51_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nri1708","volume":"5","author":"W Reith","year":"2005","unstructured":"Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5(10):793\u2013806. doi: 10.1038\/nri1708 .","journal-title":"Nat Rev Immunol"},{"key":"51_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.immunol.19.1.331","volume":"19","author":"W Reith","year":"2001","unstructured":"Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol. 2001;19:331\u201373. doi: 10.1146\/Annurev.Immunol.19.1.331 .","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"51_CR17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9440(10)63664-4","volume":"163","author":"PJ Elsen van den","year":"2003","unstructured":"van den Elsen PJ, van der Stoep N. Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not? Am J Pathol. 2003;163(1):373\u20135. doi: 10.1016\/S0002-9440(10)63664-4 .","journal-title":"Am J Pathol."},{"issue":"12","key":"51_CR18","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2002-05-1504","volume":"101","author":"J Odeberg","year":"2003","unstructured":"Odeberg J, Plachter B, Branden L, Soderberg-Naucler C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood. 2003;101(12):4870\u20137. doi: 10.1182\/blood-2002-05-1504 .","journal-title":"Blood"},{"issue":"21","key":"51_CR19","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1073\/pnas.221256498","volume":"98","author":"P Stumptner-Cuvelette","year":"2001","unstructured":"Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, et al. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A. 2001;98(21):12144\u20139. doi: 10.1073\/pnas.221256498 .","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"51_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80681-0","volume":"4","author":"CH Chang","year":"1996","unstructured":"Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 1996;4(2):167\u201378. doi: 10.1016\/S1074-7613(00)80681-0 .","journal-title":"Immunity"},{"issue":"15","key":"51_CR21","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.142298299","volume":"99","author":"M Drukker","year":"2002","unstructured":"Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99(15):9864\u20139. doi: 10.1073\/Pnas.142298299 .","journal-title":"Proc Natl Acad Sci USA."},{"issue":"7","key":"51_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF 3rd. ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol. 2013;31(7):397\u2013405. doi: 10.1016\/j.tibtech.2013.04.004 .","journal-title":"Trends Biotechnol"},{"issue":"1","key":"51_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcg.2010.12.006","volume":"38","author":"Z Wu","year":"2011","unstructured":"Wu Z, Li H, Rao L, He L, Bao L, Liao J, et al. Derivation and characterization of human embryonic stem cell lines from the Chinese population. J Genet Genomics. 2011;38(1):13\u201320. doi: 10.1016\/j.jcg.2010.12.006 .","journal-title":"J Genet Genomics"},{"issue":"Web Server issu","key":"51_CR24","doi-asserted-by":"crossref","first-page":"W117","DOI":"10.1093\/nar\/gks608","volume":"40","author":"EL Doyle","year":"2012","unstructured":"Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, et al. TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res. 2012;40(Web Server issue):W117\u201322. doi: 10.1093\/nar\/gks608 .","journal-title":"Nucleic Acids Res."},{"key":"51_CR25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-1-61779-201-4_33","volume":"767","author":"KM Silk","year":"2011","unstructured":"Silk KM, Tseng SY, Nishimoto KP, Lebkowski J, Reddy A, Fairchild PJ. Differentiation of dendritic cells from human embryonic stem cells. Methods Mol Biol. 2011;767:449\u201361. doi: 10.1007\/978-1-61779-201-4_33 .","journal-title":"Methods Mol Biol"},{"issue":"9","key":"51_CR26","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/eji.200323795","volume":"33","author":"SB Hake","year":"2003","unstructured":"Hake SB, Tobin HM, Steimle V, Denzin LK. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes. Eur J Immunol. 2003;33(9):2361\u201371. doi: 10.1002\/Eji.200323795 .","journal-title":"Eur J Immunol"},{"issue":"7","key":"51_CR27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-5890(99)00061-9","volume":"36","author":"AKF Tai","year":"1999","unstructured":"Tai AKF, Zhou G, Chau K, Ono SJ. Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription. Mol Immunol. 1999;36(7):447\u201360. doi: 10.1016\/S0161-5890(99)00061-9 .","journal-title":"Mol Immunol"},{"issue":"39","key":"51_CR28","doi-asserted-by":"crossref","first-page":"32338","DOI":"10.1074\/jbc.M112.383810","volume":"287","author":"Z Rong","year":"2012","unstructured":"Rong Z, Fu X, Wang M, Xu Y. A scalable approach to prevent teratoma formation of human embryonic stem cells. J Biol Chem. 2012;287(39):32338\u201345. doi: 10.1074\/jbc.M112.383810 .","journal-title":"J Biol Chem"},{"issue":"6","key":"51_CR29","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1634\/stemcells.2005-0299","volume":"24","author":"L Xiao","year":"2006","unstructured":"Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells. 2006;24(6):1476\u201386. doi: 10.1634\/stemcells.2005-0299 .","journal-title":"Stem Cells"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-015-0051-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:19:50Z","timestamp":1498256390000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biolres.com\/content\/48\/1\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/s40659-015-0051-6","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"article-number":"59"}}